University of Arkansas, Fayetteville

ScholarWorks@UARK
Biomedical Engineering Undergraduate Honors
Theses

Biomedical Engineering

5-2016

Microdialysis Studies Using Porcine Pancreatic Elastase to Guide
Mathematical Modeling of Microdialysis Sampling for in vivo
Measurements.
Mason W. Young
University of Arkansas, Fayetteville

Follow this and additional works at: https://scholarworks.uark.edu/bmeguht
Part of the Analytical Chemistry Commons, and the Investigative Techniques Commons

Citation
Young, M. W. (2016). Microdialysis Studies Using Porcine Pancreatic Elastase to Guide Mathematical
Modeling of Microdialysis Sampling for in vivo Measurements.. Biomedical Engineering Undergraduate
Honors Theses Retrieved from https://scholarworks.uark.edu/bmeguht/29

This Thesis is brought to you for free and open access by the Biomedical Engineering at ScholarWorks@UARK. It
has been accepted for inclusion in Biomedical Engineering Undergraduate Honors Theses by an authorized
administrator of ScholarWorks@UARK. For more information, please contact scholar@uark.edu.

Microdialysis Studies Using Porcine Pancreatic Elastase to Guide Mathematical
Modeling of Microdialysis Sampling for in vivo Measurements.

An honors thesis submitted in partial fulfillment
of the requirements for Honors Studies in
Biomedical Engineering

By
Mason Young

2016
Biomedical Engineering
College of Engineering
The University of Arkansas

Young 1

Acknowledgements


My research instructor, Dr. Julie A. Stenken



Kamel Alkhatib for personally helping me along the way with my project



The rest of the Stenken Lab group



Honors College, University of Arkansas

Young 2

Table of Contents
1. ABSTRACT............................................................ ERROR! BOOKMARK NOT DEFINED.
2. INTRODUCTION ...................................................................................................... 5
2.1 OVERVIEW OF EXPERIMENT .............................................................................................. 5
2.2 MICRODIALYSIS SAMPLING ............................................................................................... 5
2.2.1 Microdialysis Sampling- Basic Setup and Usage ................................................ 5
2.2.2 Quantification of Concentrations in Microdialysis Dialysate ............................. 8
2.3 MATRIX METALLOPROTEINASES ...................................................................................... 10
3. MATERIALS AND METHODS ................................................................................ 122
3.1 CHEMICALS ................................................................................................................. 12
3.2 INSTRUMENTS.................................................................ERROR! BOOKMARK NOT DEFINED.2
3.3 PORCINE PANCREATIC ELASTASE ACTIVITY ............................... ERROR! BOOKMARK NOT DEFINED.
3.3.1 Porcine Pancreatic Elastase Degradation ........................................................ 14
3.4 MEASURING COLLECTED P-NA AND SUC-(ALA)3-PNA CONCENTRATIONSERROR! BOOKMARK NOT DEFINED.
4. RESULTS AND DISCUSSION .................................................................................... 15
4.1 DEGRADATION OF STORED ELASTASE SOLUTIONS................................................................ 15
4.2 ELASTASE ACTIVITY ....................................................................................................... 18
4.3 MEASURING COLLECTED P-NA AND SUC-(ALA)3-PNA ......................................................... 20
4.3.1 Generation of Calibration Curves ..................................................................... 20
4.3.2 Translation from Absorbance Values to Concentration Values ....................... 24
5. CONCLUSION. ....................................................................................................... 29
6. REFERENCES ......................................................................................................... 31

Young 3

1. Abstract
Microdialysis sampling uses a semi-permeable membrane to allow solute collection by
diffusion. When used in conjunction with other instruments, analytes in question can be
quantified. Matrix Metalloproteinases (MMPs) are enzymes involved in numerous biological
processes where they serve the role of degrading extracellular matrix. Microdialysis sampling,
in coordination with further analysis methods, can be used in order to measure the activity of
these enzymes in a region of the body instantaneously. The intention of this project is to
determine ways of measuring in vitro activity of elastase from porcine pancreas using
determined activity values and the collection of elastase products. This is a necessary step in
the advancement of this technology towards in vivo research. Elastase from the porcine
pancreas is a substitute for MMP in vivo. Experiments were performed using succinyl(Ala)3 -pnitroaniline, 4-nitroanaline, and elastase from porcine pancreas. The Nanodrop, a UV-Vis
instrument, was used in order to measure the concentration of p-nitroaniline (p-NA) using its
maximum absorbance at a wavelength of 380 nm. A microdialysis probe with a molecular cutoff
of 20 kDa was used in order to collect p-NA from solution and transfer it into collection vials for
analyzation of p-NA concentration. The concentration of p-NA increased over time until it
reached a point where it would level off. This level-off value varied based upon the
concentration of the suc-(Ala)3-pNA perfusate. Experiments showed a decrease in activity of
elastase with decreasing concentrations or increasing storage time. In microdialysis sampling
experiments, the concentration of suc-(Ala)3-pNA in the samples collected showed a decrease
as the concentration of the pNA collected increased.
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2. Introduction

2.1 Overview of Experiment
This research chiefly focuses on the enzyme elastase derived from the porcine pancreas
in addition to succinyl(Ala)3 -p-nitroaniline, the commonly used substrate, and 4-nitroaniline,
the product of the reaction between the two chemicals previously mentioned. The long term
goal of this research is to be able to measure the activity of an enzyme in vivo using known
perfusate concentrations and concentration of specific chemicals in the collected solution. The
measurement of in situ biochemistry would allow for real-time activities to be measured and
analyzed, allowing further conclusions regarding the nature of biochemistry in vivo. It is
necessary to conclude accurate results; there is a necessity for increased confidence when
performing in vivo analysis. The onset of this project centered on the activity of the elastase
enzyme at different concentrations in sodium phosphate buffer (pH= 7.1.) After several
experiments using the TECAN instrument, focus shifted to the measurement of p-NA collected
from the microdialysis probe inserted in a solution of elastase (at varying concentrations) with
succinyl(Ala)3 -p-nitroaniline being used as the substrate. The final objective of this project is to
be able to accurately measure the activity of the elastase enzyme in solution using the
calculated activity and the concentrations of p-NA collected through microdialysis methods.
2.2 Microdialysis Sampling
2.2.1 Microdialysis Sampling- Basic Setup and Usage
Microdialysis is a sampling technique that uses concentration-based passive diffusion of
solutes across a semi-permeable hollow-fiber membrane to collect analytes from a solution.

Young 5

Microdialysis probes consist of inlet and outlet tubes leading to/away from the cylindrical
semipermeable membrane of the probe. The inlet tube carries the perfusate, to be released
through the semipermeable membrane into solution, while the outlet tube carries the dialysate
collected through the same semipermeable membrane in the same solution. The basic set-up of
a microdialysis probe can be seen in Figure 1. The semipermeable membrane is unique to the
type of probe purchased; different probes have membranes with different molecular weight
cutoffs in order to specify the analytes to be collected. The molecular weight cutoff of the
probes used in these experiments is 20 kDa.

Figure 1. Schematic representation of a microdialysis probe with inlet and outlet flow
represented.1

Microdialysis sampling as a whole consists of four separate devices: a syringe, syringe
pump, microdialysis probe, and collection vial are all used during the course of sampling. The
syringe contains the perfusate to be pumped into the inlet tube of the microdialysis probe, as
Young 6

detailed above. The syringe pump flows the perfusate into the probe at slow rates; flow rates
are maintained at less than 4μL/min in order to prevent damage to the microdialysis probe
membrane. The collection vial is placed at the end of the outlet tube to collect the dialysate, a
sample of fluid that comes from the solution and is representative of the composition of said
solution. The typical setup is shown below in Figure 2.

Figure 2. Image detailing typical set up of in vitro microdialysis sampling experiment. Syringe
pump loaded with syringes can be seen on the left, connected to the microdialysis probe in
solution, with the outlet running to a vial on the right.

Microdialysis methods can be used in conjunction with other analytical measurement
techniques to monitor the real-time levels of analyte concentration in vivo. This is useful during
in vivo studies, as previously it was necessary for animals to be sacrificed at each time interval
so that measurements could be made. With microdialysis sampling, the animal being studied
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can be kept alive through the duration of the sampling and real-time results from microdialysis
sampling can be obtained simultaneously.
Microdialysis research began as a tool for measuring neurotransmitters in the brain but
the application of this sampling method has since broadened. In part because of its minimally
invasive nature, it has grown as an in vivo sampling option for molecules within the
extracellular space of many tissues and body fluids, including blood and cerebrospinal fluid
(CSF.) It is now used for studies in nearly every organ.2

2.2.2 Quantification of Concentrations in Microdialysis Dialysate
Once the dialysate from the microdialysis probe is collected in vials, specific methods
are needed in order to quantify the amount of the targeted analyte. The fraction of product
obtained is related to the concentration of the enzyme in solution. Analyte concentrations
obtained from the dialysate can be related to the concentration in solution by using the
membrane extraction efficiency.3 In Equation 1, EE represents the extraction efficiency, and the
Coutlet represents the concentration of the analyte in the outlet (dialysate), Cinlet the
concentration of the analyte in the inlet (perfusate), and Csample the concentration of the
analyte in the sample solution far away from the probe.3
𝐶

−𝐶

𝐸𝐸 = 𝐶 𝑜𝑢𝑡𝑙𝑒𝑡 −𝐶𝑖𝑛𝑙𝑒𝑡
𝑠𝑎𝑚𝑝𝑙𝑒

(1)4

𝑖𝑛𝑙𝑒𝑡

There are many different variations of microdialysis sampling technique that affect the
recovery rate. The molecular weight cutoff of the probe must be such that the analyte in
question will have the ability to leave the probe and also reenter, while other substances may
not cross this probe membrane. Microdialysis probes with 20 kiloDalton (kDa) and 100 kDa
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probes were used in lab, but for these experiments 20 kDa was used. This cutoff will not allow
any molecule over a certain size to pass through the pores. The relative recovery of a molecule
with size above the molecular weight cutoff will be very small, while a molecule under this
cutoff may remain high, with other factors to define the relative recovery. The diffusion
coefficient of the analyte must also be taken into account with regards to microdialysis
sampling. Varying diffusion coefficients will affect the recovery of analyte and the
corresponding dialysate.
The flow rate of the perfusate will also lead to variations in the relative recovery.4 With
slower flow rates, the perfusate will have more time to interact with enzymes in the solution,
and thus the concentration of the analyte at the outlet will be increased. With faster flow rates,
there is not as much time for a reaction to occur, so the analyte in question will have lower
concentrations. This is modeled below in Figure 3, which shows a mathematical simulation of
relative recovery (RR) is based upon the flow rate of the perfusate.

Figure 3. Simulated relative recovery (RR) curves as a function of perfusion flow rates in
microliters/minute. This uses Bungay’s model for glucose (black), insulin (red), and MCP-1
(green).8
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These factors must be taken into account when comparing relative recovery between
experiments with different parameters. The relative recovery depends upon more than just
concentration of enzymes and the perfusate, it also depends upon the flow rate and molecular
weight cutoff of the experimental setup.

2.3 Matrix Metalloproteinases

Matrix metalloproteinases (MMPs), also referred to as matrixins, have been associated
with the degradation and turnover of most of the components of the extracellular matrix
(ECM).6 MMPs all share a conserved zinc-binding motif in their catalytic site.10 These enzymes
have recently been researched for their function as regulators of extracellular tissue signaling
networks in addition to the degradation of ECM.10 These metalloproteinases play a role in
numerous biological processes. MMPs play an important role in embryogenesis, normal tissue
remodeling, wound healing, and angiogenesis, to name a few processes.8 MMPs are
upregulated in diseases such as atheroma, arthritis, cancer and tissue ulceration.11 There are
currently 23 different MMPs identified in humans, each with varying functions.11 MMPs are
difficult to quantify using traditional immunochemical methods because the total enzyme
concentration does not accurately portray the concentration of active enzyme. MMPs are
released as pro-enzymes into the ECM and then are converted here into their active form.12
These two forms cannot be distinguished between by immunochemical methods, so
microdialysis methods are being developed to measure the MMP activity values in real-time.12
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MMP-12 is one of these enzymes which degrade elastin in the extracellular matrix.12
MMP-12 is also known as macrophage metalloelastase and is the predominant cell type which
patrols the lower airspaces of the lungs under normal conditions.12 This enzyme is important in
current research because of the similarity to porcine pancreatic elastase. Porcine pancreatic
elastase is used in experiments as a substitute for MMP-12 because the cost is far lower and
the function is very similar to that of MMP-12, in that each cleaves the same substrate. Porcine
pancreatic elastase cleaves succinyl-L-trialanine p-nitroanilide in order to form p-Nitroaniline
(p-NA) and another product, as shown in Figure 4 below.

Figure 4. Schematic for indirect detection of elastase. Example of MMP-12-like elastase
cleavage of Suc(Ala)3-p-NA as used in experiments. Note: HPLC was not used in the following
experiments as listed on the figure.13

This p-NA product is useful in research because the concentration can be measured
using the absorbance values of a corresponding solution. Collected p-NA was analyzed on the
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NanoDrop instrument to measure the absorbance value of the solution. This was able to be
converted into concentration values.

3. Materials and Methods
3.1 Chemicals
Succinyl(Ala)3 -p-nitroaniline, 4-nitroanaline, and porcine pancreatic elastase were all
used in the experiments conducted in lab. All chemicals were acquired from Sigma in St. Louis,
Missouri. When conducting experiments, 1000 µM elastase and succinyl(Ala)3-p-nitroaniline
solutions in sodium phosphate buffer (pH=7.1) were prepared fresh at the beginning of each
day. Degradation of these materials was found when stored. The maximum absorbance of both
succinyl(Ala)3-p-nitroaniline and 4-nitroanaline were found in previous experiments to be 315
nm and 380 nm, respectively.14 The molecular weight of suc(Ala)3-p-NA is 451.43 Daltons5, the
molecular weight for p-Nitroaniline is 138.12 Daltons6, and the molecular weight of the elastase
enzyme is 25.9 kDa7; the membrane used keeps the enzyme from passing.

3.2 Instruments
CMA 20 Elite 10mm microdialysis probes from CMA Microdialysis with a molecular
weight cutoff of 20 kDa were used during experiments. Both the pump and the 1 mL syringe
used were from BASi. A NanoDrop 2000c spectrophotometer from Thermo Scientific was used
in conjunction with NanoDrop 2000 software in order to measure the absorbance of solutions
collected. 2 µL samples were analyzed by the NanoDrop instrument. A TECAN instrument,
model infinite M200, was used with corresponding TECAN i-control software in order to
Young 12

measure the activity of the porcine panctreatic elastase over time. 100 µL samples were
analyzed by the TECAN instrument to measure absorbance over time as the reaction of elastase
and succinyl(Ala)3 -p-nitroaniline proceeded.

3.3 Porcine Pancreatic Elastase Activity

The activity of elastase was measured using the TECAN instrument, which is
capable of measuring absorbance over time as the reaction of elastase and succinyl(Ala)3 -pnitroaniline proceeded. A 96 well plate was used, and 50 microliters of 500 micromolar
succinyl(Ala)3 -p-nitroaniline was combined with 50 microliters of porcine pancreatic elastase at
different concentrations to test for the activity of the enzyme. Elastase concentrations of 1, 0.5,
and 0.25 units per milliliter were used in these experiments.
The following screenshot (Figure 5) was obtained from TECAN i-control software which
was used during each run of porcine pancreatic elastase and succinyl(Ala)3 -p-nitroaniline. A
kinetic cycle was run with readings in each highlighted well every 15 seconds. Absorbance
values of 380 nm and 315 nm were each obtained to track the activity of the elastase enzyme.
Movement of the plate was also added into the code, as proper mixing was difficult at such
small volumes.
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Figure 5. TECAN i-control software code for each run of porcine pancreatic elastase and
succinyl(Ala)3 -p-nitroaniline. Absorbance values were calculated at every 15 second interval for
each well.
3.3.1 Porcine Pancreatic Elastase Degradation

During measurement of porcine pancreatic elastase activity, it was noticed that the
activity was greatly decreased upon storage. Experiments were run using the TECAN and slopes
were compared between freshly-made enzyme solution and solution stored for one day. The
same TECAN i-control software was used as above, and the slopes were compared using
Microsoft Excel.

3.4 Measuring Collected p-NA and suc-(Ala)3-pNA Concentrations

Once the dialysate from the microdialysis probe is collected in vials, the absorbance
must be measured in order to determine the concentration of both pNA and suc-(Ala)3-pNA
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collected. In order to determine the concentration of each substance, calibration curves are
developed before the experiment begins and used to compare the absorption values measured
from the collection vial.
Calibration curves are created at both 315 nm, the peak absorbance of suc-(Ala)3-pNA,
and 380 nm, the peak absorbance of pNA, for both substances, resulting in 4 calibration curves.
Using the measured absorbance of our dialysate, matrix algebra can be used in order to
determine the concentration of both pNA and suc-(Ala)3-pNA. The following Equations 3-6
represent the mathematics that was followed in order to determine each concentration value,
where 𝐴 represents the total absorbance of the dialysate, ∈ represents the slope of the
calibration curve for the corresponding grah, 𝐶𝑥 represents the concentration of x, ℓ is the
pathlength of the light (this is a constant and can thus be ignored in succeeding equations), and
𝜆1 and 𝜆2 represent the wavelength of light used. For this experiment, 𝜆1 was 315 nm and 𝜆2
was 380 nm.
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆1 ) =∈𝑝𝑁𝐴(𝜆1 ) ℓ 𝐶𝑝𝑁𝐴 + ∈suc−(Ala)3−pNA(𝜆1 ) ℓ 𝐶suc−(Ala)3−pNA

(3)

𝐴𝑇𝑜𝑡𝑎𝑙(𝜆2 ) =∈𝑝𝑁𝐴(𝜆2 ) ℓ 𝐶𝑝𝑁𝐴 + ∈suc−(Ala)3−pNA(𝜆2 ) ℓ 𝐶suc−(Ala)3−pNA

(4)

∈𝑝𝑁𝐴(𝜆1 )
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆1 )
(
) = (∈
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆2 )
𝑝𝑁𝐴(𝜆2 )

(5)

∈𝑝𝑁𝐴(𝜆1 )
(∈
𝑝𝑁𝐴(𝜆2 )

∈suc−(Ala)3−pNA(𝜆1 )
𝐶𝑝𝑁𝐴
)
(
∈suc−(Ala)3−pNA(𝜆2 ) 𝐶suc−(Ala)3−pNA )

∈suc−(Ala)3−pNA(𝜆1 ) −1 𝐴𝑇𝑜𝑡𝑎𝑙(𝜆1 )
𝐶𝑝𝑁𝐴
)
(
)
=
(
)
∈suc−(Ala)3−pNA(𝜆2 )
𝐶suc−(Ala)3−pNA
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆2 )

(6)

Following the mathematical steps outline in Equations 3-6, the absorbance values
obtained from the NanoDrop instrument for the dialysate were converted into concentration
values using Microsoft Excel.
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4. Results and Discussion
4.1 Degradation of Stored Elastase Solutions
During the testing of porcine pancreatic elastase activity, it was noted that there was a
vast difference between activity on the day the solution was created and on the following day.
Porcine pancreatic elastase was diluted in sodium phosphate buffer with a pH of 7.1, and
stored frozen at -20 C for use later. However, when thawed and tested the next day a large
drop-off was seen. In order to test for this drop-off, experiments were run to show the
difference between the first day and the next day, as shown in Figure 6 and 7.

Activity of Porcine Pancreatic Elastase in Sodium Phosphate Buffer
Solution (Temp= 20 C, pH= 7.1)
0.59

Absorbance

0.54
0.49

Well B2; 1
unit/mL Elastase

0.44
Well B3; 1
unit/mL Elastase

0.39
0.34
0

200

400

600

800

Time (s)

Figure 6. Absorbance values as a function of time as measured on the TECAN instrument.
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in B2 at 1 unit/mL
is 3.17 x 10-4 s-1 and slope in B3 at 1 unit/mL is 3.20 x 10-4 s-1.
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Activity of Porcine Pancreatic Elastase in Sodium Phosphate Buffer
Solution (Temp= 20 C, pH= 7.1)
0.59

Absorbance

0.54
0.49

Well A2; 1 unit/mL
Elastase

0.44
Well A3; 1 unit/mL
Elastase

0.39
0.34
0

100

200

300

400

500

600

Time (s)

Figure 7. Absorbance values as a function of time as measured on the TECAN instrument.
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in A2 at 1 unit/mL
is 1.09 x 10-4 s-1 and slope in A3 at 1 unit/mL is 1.21 x 10-4 s-1.

In Figure 6, the slopes are .000317 and .000320 for 1 unit/mL fresh elastase enzyme,
and in Figure 7 the slopes are .000109 and .000121 for day-old enzyme solution. Clearly, a large
decrease was seen in the slopes for the elastase enzyme from one day to the next. It was
decided that it would be necessary to make a fresh solution of pancreatic porcine elastase and
sodium phosphate buffer (pH = 7.1) in order to prevent this decreased activity. This degradation
of the elastase enzyme would have created issues in microdialysis sampling experiments should
stored samples have been used when running experiments.
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4.2 Elastase Activity
Porcine pancreatic elastase activity was measured by first determining the slope of the
absorbance as a function of time and comparing between different parameters. This project
started with comparing activity between solutions with different concentrations of the elastase
enzyme. Samples with 0.25 unit/mL, 0.5 unit/mL and 1 unit/mL elastase were compared to see
differences in slopes. It was determined that the slope was decreased when the concentration
of the enzyme in solution was decreased. The data points generated by the TECAN instrument
were transferred to Microsoft Excel in order to generate Figures 8, 9, and 10 below.
Activity of Porcine Pancreatic Elastase in Sodium Phosphate Buffer
Solution (Temp= 20 C, pH= 7.1)

0.59

Absorbance

0.54
Well B2; 1
unit/mL Elastase

0.49
0.44

Well B3; 1
unit/mL Elastase

0.39
0.34

0

200

400
Time (s)

600

800

Figure 8. Absorbance values as a function of time as measured on the TECAN instrument.
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in B2 at 1 unit/mL
is 3.17 x 10-4 s-1 and slope in B3 at 1 unit/mL is 3.20 x 10-4 s-1.
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Activity of Porcine Pancreatic Elastase in Sodium Phosphate
Buffer Solution (Temp= 20 C, pH=7.1)
0.45

Absorbance

0.4
Well E2; .5
unit/mL Elastase

0.35

0.3
Well E3; .5
unit/mL Elastase

0.25
0.2
0

200

400
Time (s)

600

800

Figure 9. Absorbance values as a function of time as measured on the TECAN instrument.
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in E2 at 0.5
unit/mL is 1.65 x 10-4 s-1 and slope in E3 at 0.5 unit/mL is 1.63 x 10-4 s-1.

0.42

Activity of Porcine Pancreatic Elastase in Sodium Phosphate
Buffer Solution (Temp= 20 C, pH=7.1)

0.41

Absorbance

0.4
0.39

Well A2; .25
unit/mL Elastase

0.38

Well A3; .25
unit/mL Elastase

0.37
0.36
0.35
0

200

400

600

800

Time (s)

Figure 10. Absorbance values as a function of time as measured on the TECAN instrument.
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in A2 at 0.25
unit/mL is 7.55 x 10-5 s-1 and slope in A3 at 0.25 unit/mL is 7.48 x 10-5 s-1.

To organize the graphs above, Table 1 was created. It gives the values of the slope for
each well, where each concentration of elastase was run in duplicate.
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Table 1. Slope of absorbance values as a function of time for different concentrations of porcine
pancreatic elastase in sodium phosphate buffer (pH=7.1). Average slope at each elastase
concentration has also been calculated in Column 4.
Slope Values (s-1)
Average Slope (s-1)
Elastase Conc.
1 unit/mL

3.17 x 10-4

3.20 x 10-4

3.185 x 10-4

0.5 unit/mL
0.25 unit/mL

1.65 x 10-4

1.63 x 10-4

1.64 x 10-4

7.55 x 10-5

7.48 x 10-5

7.515 x 10-5

It can be seen in Table 1 that there is a decrease in the average slope as the elastase
concentration decreases. This seems to coincide with the idea that there will be less activity
when there is less enzyme available. Because of the lower activity, there is a smaller change in
the absorbance over time and thus a less steep graph. By calculating the activity at each
concentration, these values can be used in order to create a mathematical modelling system to
determine the concentration of elastase during an in vivo sampling procedure.
4.3 Measuring Collected p-NA and suc-(Ala)3-pNA
In order to measure the concentration of the collected pNA and suc-(Ala)3-pNA,
calibration curves must first be developed for each chemical. These calibration curves will be
used in the matrix algebra necessary for calculation of concentrations. Upon the determination
of calibration curves on the NanoDrop instrument, the absorbance values of our collected
dialysate can be used in order to determine the concentration of analytes collected.
4.3.1 Generation of Calibration Curves
To create the p-NA calibration curve, a solution of 1000 micromolar p-NA was created
using roughly 1.38 mg p-NA in 10 mL of sodium phosphate buffer, and then mixed on a mixing
plate with a magnetic stir bar and very low heat. After about 30 minutes, when there was no
more p-NA visible, the solution was removed from the mixing plate. At this point, 1 mL was
Young 20

placed into a vial labelled 1000 µM. 7 other vials were then used in order to create a serial
dilution of p-NA with concentrations of 500 µM, 250 µM, 125 µM, 62.5 µM, 31.25 µM, 15.625
µM, 7.8125 µM, and 3.90625 µM. Each vial was mixed thoroughly to ensure uniform
concentrations of p-NA. A 2 µL sample of each was then run on the NanoDrop instrument in
order to determine the absorbance value at each concentration. Absorbance values were
calculated at both 315 nm and 380 nm. Each vial was run in triplicate. Figures 11 and 12
(below) were generated using absorbance values.

pNA Calibration Curve at 315 nm (Conc vs.
Absorbance)
0.5

y = 0.0004x - 0.001
R² = 0.9998

Absorbance

0.4
0.3
0.2
0.1
0
0

200

400
600
800
Concentration (uM)

1000

1200

Figure 11. Calibration curve for p-NA solutions between 3.90625 micromolar and 1000
micromolar concentrations at a wavelength of 315 nm. (Slope= 4.129 x 10-4)
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Absorbance

pNA Calibration Curve at 380 nm (Conc vs.
Absorbance)
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0

y = 0.0015x - 0.0004
R² = 0.9997

0

200

400
600
800
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1000

1200

Figure 12. Calibration curve for p-NA solutions between 3.8 micromolar and 1000 micromolar
concentrations at a wavelength of 380 nm. (Slope= 1.495 x 10-3)
To create the suc-(Ala)3-pNA calibration curve, a solution of 1000 micromolar suc-(Ala)3pNA was created using roughly .9029 mg suc-(Ala)3-pNA in 2 mL of sodium phosphate buffer
(pH=7.1), and then mixed on a mixing plate with a magnetic stir bar. Because suc-(Ala)3-pNA is
much more soluble that p-NA, it does not need heat or as much time to fully dissolve. After a
few minutes of mixing, the solution was removed from the mixing plate. At this point, 1 mL was
placed into a vial labelled 1000 µM. 7 other vials were then used in order to create a serial
dilution of p-NA with concentrations of 500 µM, 250 µM, 125 µM, 62.5 µM, 31.25 µM, 15.625
µM, 7.8125 µM, and 3.90625 µM. Each vial was mixed thoroughly to ensure uniform
concentrations of suc-(Ala)3-pNA. A 2 µL sample of each was then run on the NanoDrop
instrument in order to determine the absorbance value at each concentration. Absorbance
values were calculated at both 315 nm and 380 nm. Each vial was run in triplicate. Figures 13
and 14 (below) were generated from the absorbance values obtained.
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Figure 13. Calibration curve for suc-(Ala)3-pNA solutions between 3.60925 micromolar and 1000
micromolar concentrations at a wavelength of 315 nm. (Slope= 1.348 x 10-3)

suc-(Ala)3-pNA Calibration Curve at 380 nm
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Figure 14. Calibration curve for suc-(Ala)3-pNA solutions between 3.60925 micromolar and 1000
micromolar concentrations at a wavelength of 380 nm. (Slope= 1.164 x 10-4)

Slopes were then collected from each graph in order to plug into Equations 3-6 as
described above. To simplify the charts above, a 2x2 matrix of the slopes was created with
orientation identical to that of Equation 5. Table 2 shows the slopes of each graph that was
generated for the calibration curves of p-NA and suc-(Ala)3-pNA at 315 nm and 380 nm.
Young 23

Table 2. Slope values for each generated calibration curve for p-NA and suc-(Ala)3-pNA at 315
nm and 380 nm. Solutions contained p-NA or suc-(Ala)3-pNA at different concentrations in
sodium phosphate buffer (pH=7.1).
Wavelength (nm)
315

380

p-NA

4.129 x 10-4

1.495 x 10-3

suc-(Ala)3-pNA

1.348 x 10-3

1.164 x 10-4

These values for the slope of each calibration curve were inserted into Equation 5 as
listed above. The matrix in Equation 7 was obtained.
∈𝒑𝑵𝑨(𝝀𝟏 )
(∈
𝒑𝑵𝑨(𝝀𝟐 )

∈suc−(Ala)3−pNA(𝝀𝟏)
∈𝒑𝑵𝑨(𝟑𝟏𝟓𝒏𝒎)
∈suc−(Ala)3−pNA(𝝀𝟐) ) = (∈𝒑𝑵𝑨(𝟑𝟖𝟎𝒏𝒎)

∈suc−(Ala)3−pNA(𝟑𝟏𝟓𝒏𝒎)
. 0004129
∈suc−(Ala)3−pNA(𝟑𝟖𝟎𝒏𝒎) ) = ( . 001495

.001348
)
. 0001164

(7)

4.3.2 Translation from Absorbance Values to Concentration Values
To translate the absorbance values collected at each time point to values of
concentration for p-NA and suc-(Ala)3-pNA, Equations 3-7 were used. Absorbance values of
wells were gathered in triplicate, and the concentrations associated were found using
Equations 8 and 9 below, where 𝐴𝑇𝑜𝑡𝑎𝑙(315𝑛𝑚) represents the absorbance value of the vial at
315 nm, and 𝐴𝑇𝑜𝑡𝑎𝑙(380) represents the absorbance value of the value measured with
wavelength of 380 nm.
∈𝑝𝑁𝐴(315𝑛𝑚)
(∈
𝑝𝑁𝐴(380𝑛𝑚)
(

∈suc−(Ala)3−pNA(315𝑛𝑚) −1 𝐴𝑇𝑜𝑡𝑎𝑙(315𝑛𝑚)
𝐶𝑝𝑁𝐴
)
(
)
=
(
)
∈suc−(Ala)3−pNA(380𝑛𝑚)
𝐶suc−(Ala)3−pNA
𝐴𝑇𝑜𝑡𝑎𝑙(380𝑛𝑚)

. 0004129
. 001495

.001348 −1 𝐴 𝑇𝑜𝑡𝑎𝑙(315𝑛𝑚)
) (
)
𝐴𝑇𝑜𝑡𝑎𝑙(380𝑛𝑚)
. 0001164

=(

𝐶𝑝𝑁𝐴
𝐶suc−(Ala)3−pNA

(8)

)

(9)

Matrix algebra was used in order to determine the concentrations of p-NA and suc(Ala)3-pNA and graphs were created from these calculated data points, as shown below in
Figures 15-20.
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Figure 15. Concentration of p-NA as a function of time. Samples were collected and measured
every 5 minutes for 65 minutes. 500 micromolar suc-(Ala)3-pNA was flowed at 1 microliter per
minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine pancreatic elastase,
diluted in sodium phosphate buffer (pH=7.1.)
Concentration suc-(Ala)3-pNA vs. Time (500uM suc(Ala)3-pNA at 1 uL/min in 0.5 unit/mL elastase
solution)
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Figure 16. Concentration of suc-(Ala)3-pNA as a function of time. Samples were collected and
measured every 5 minutes for 65 minutes. 500 micromolar suc-(Ala)3-pNA was flowed at 1
microliter per minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine
pancreatic elastase, diluted in sodium phosphate buffer (pH=7.1.)

Figure 15 shows an increase in the concentration of p-NA, as expected. It does show a
levelling-off of the p-NA concentration collected around 40 minutes in the 45-50 micromolar
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range. The concentration of suc-(Ala)3-pNA shown in Figure 16 shows a steep drop-off from the
5 minute sample to the 10 minute sample, but then a levelling-off after this point. The suc(Ala)3-pNA concentration levels off around 250 micromolar in each subsequent sample.

Concentration pNA vs. Time (500uM suc-(Ala)3-pNA
at 1 uL/min in 1 unit/mL elastase solution)
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Figure 17. Concentration of p-NA as a function of time. Samples were collected and measured
every 5 minutes for 65 minutes. 500 micromolar suc-(Ala)3-pNA was flowed at 1 microliter per
minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine pancreatic elastase,
diluted in sodium phosphate buffer (pH=7.1.)
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Concentration suc-(Ala)3-pNA vs. Time (500uM suc(Ala)3-pNA at 1 uL/min in 1 unit/mL elastase
solution)
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Figure 18. Concentration of suc-(Ala)3-pNA as a function of time. Samples were collected and
measured every 5 minutes for 65 minutes. 500 micromolar suc-(Ala)3-pNA was flowed at 1
microliter per minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine
pancreatic elastase, diluted in sodium phosphate buffer (pH=7.1.)

Figure 17 shows an increase in the concentration of p-NA once again, as expected. It
does show a levelling-off of the p-NA concentration collected around 20 minutes in the 60-70
micromolar range. The data point at 30 minutes with a concentration of 93.875 micromolar pNA appears to be an outlier. This experiment was run with the same parameters as the one
which generated the preceding Figures 15 and 16. However, the p-NA concentration measured
leveled off at different times and at different values. This may be due to small errors in the
concentration of any substrate used or differences in the flow rate of two different syringe
pumps. This experiment would need to be run several more times in order to produce
replicable values. It does appear from these two graphs that the general shape and behavior of
the concentrations is consistent with one another, the values just vary. The concentration of
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suc-(Ala)3-pNA shown in Figure 18 shows a gradual drop-off for most of the first 60 minutes,
with a sudden rise at 65 minutes.

Concentration pNA vs. Time (1000uM suc-(Ala)3pNA at 1 uL/min in 1 unit/mL elastase solution)
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Figure 19. Concentration of p-NA as a function of time. Samples were collected and measured
every 5 minutes for 45 minutes. 1000 micromolar suc-(Ala)3-pNA was flowed at 1 microliter per
minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine pancreatic elastase,
diluted in sodium phosphate buffer (pH=7.1.)
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Figure 20. Concentration of suc-(Ala)3-pNA as a function of time. Samples were collected and
measured every 5 minutes for 45 minutes. 1000 micromolar suc-(Ala)3-pNA was flowed at 1
microliter per minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine
pancreatic elastase, diluted in sodium phosphate buffer (pH=7.1.)
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Figure 19 shows an increase in the concentration of p-NA once again, in a similar fashion
the preceeding experiments. It shows a levelling-off of the p-NA concentration collected around
30 minutes in the 125-135 micromolar range. This experiment was run with slightly different
parameters as the one which generated the preceding Figures 15-18. The flow rate was the
same, as was the concentration of the enzyme. The concentration of the perfusing suc-(Ala)3pNA solution was doubled to 1000 micromolar. This did create a rough doubling of the levelingoff concentration for p-NA. The concentration of suc-(Ala)3-pNA measured, and portrayed in
Figure 20, appears to have no correlation. This is not expected; it was expected that the
concentration of suc-(Ala)3-pNA would decrease over time. To rise and fall with such drastic
values does not seem to satisfy this expected outcome. This may be due to the high
concentration of suc-(Ala)3-pNA and so slight changes may be amplified in the calculated
concentrations. This experiment would need to be run several more times in order to produce
replicable values for the concentration values over time in order to create a mathematical
model for the measurement of in vivo concentration for such an enzyme.

5. Conclusion

Research into the activity of porcine pancreatic elastase revealed differences in the
slope of absorbance as a function of time when elastase and suc-(Ala)3-pNA were combined in a
well. Different enzyme concentrations altered the slope (steeper for higher concentrations) and
time in storage also created differences in activity. It was determined that the activity of
enzyme solutions stored for a day was much lower than fresh solutions. Further research is
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currently being conducted to determine reproducible results regarding the activity of porcine
pancreatic elastase at different concentrations and with different factors altered. During
microdialysis research using suc-(Ala)3-pNA as the perfusate and elastase as the enzyme, the
concentration of p-nitroaniline collected increased at each early time point, signifying that the
microdialysis setup was working as expected. The values obtained for the suc-(Ala)3-pNA
concentration were not as expected, however. In one the third experiment, shown in Figure 20,
the concentrations do not appear to be correlated in any way. These experiments should be run
several more times in order to produce replicatable results in order to use the information
gained to develop a mathematical model of measuring in vivo enzyme concentration
accurately.
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